News

CDC: Adult Immunization Rates Slowly Improving


 

The NFID has a new dedicated adult vaccination Web site for patients, www.adultvaccination.com.

Dr. Rehm has served as a speaker for Sanofi-Pasteur and Genentech, as a speaker and principal adviser for a research study for Cubist Pharmaceuticals Inc., and as an advisory committee member for Pfizer Inc. and Merck & Co. Inc. Dr. Wharton is an employee of CDC with no financial disclosures.

Pages

Recommended Reading

FDA: New IV Antibiotic for MRSA Approved
MDedge Dermatology
Reports Claim FDA Blocking Importation of Cantharidin
MDedge Dermatology
Parasitic Infections Often Found in Impoverished Areas
MDedge Dermatology
Agents in Pipeline May Help Combat MRSA
MDedge Dermatology
Gonorrhea Drifting Toward Cephalosporin Resistance
MDedge Dermatology
Common Sense Policy Boosts Vaccination of Health Care Workers
MDedge Dermatology
FDA: Tesamorelin Approved for Lipodystrophy in HIV
MDedge Dermatology
Mangosteen
MDedge Dermatology
Drug-Resistant Klebsiella Pneumoniae a Growing Problem
MDedge Dermatology
FDA Committee Considers Gardasil for Anal Cancer Prevention
MDedge Dermatology